Najarian et al., 1992 - Google Patents
Renal transplantation in the first year of life: the treatment of choice for infants with end-stage renal disease.Najarian et al., 1992
View PDF- Document ID
- 12465207294603233318
- Author
- Najarian J
- Almond P
- Mauer M
- Chavers B
- Nevins T
- Kashtan C
- Matas A
- Publication year
- Publication venue
- Journal of the American Society of Nephrology
External Links
Snippet
The treatment of choice for end-stage renal failure within the first year of life is controversial. Between September 1970 and February 1991, we performed 28 kidney transplants (27 primary, 1 retransplant, 23 living donor, 5 cadaver) in infants less than 1 yr of age (mean, 7+ …
- 230000000268 renotropic 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bywaters et al. | Crush injuries with impairment of renal function | |
Aessopos et al. | Pulmonary hypertension in β‐thalassemia | |
Washer et al. | Causes of death after kidney transplantation | |
Hobart et al. | TRANSPLANTATION OF PEDIATRIC EN BLOC CADAVER KIDNEYS INTO ADULT RECIPIENTS1 | |
Kim et al. | A simplified protocol using rituximab and immunoglobulin for ABO‐incompatible low‐titre living donor liver transplantation | |
Karkar | Continuous renal replacement therapy: Principles, modalities, and prescription | |
Briscoe et al. | Outcome of renal transplantation in children less than two years of age | |
Najarian et al. | Renal transplantation in the first year of life: the treatment of choice for infants with end-stage renal disease. | |
Rizzoni et al. | Renal transplantation in children less than 5 years of age. | |
Muramatsu et al. | Transplantation of adult‐size kidneys in small pediatric recipients: A single‐center experience | |
Druml et al. | Pancreatitis in acute hemolysis | |
Chavers et al. | Kidney transplantation in infants and small children | |
Movilli et al. | Effect of age on protein catabolic rate, morbidity, and mortality in uraemic patients with adequate dialysis | |
Tydén et al. | RENAL TRANSPLANTATION IN CHILDREN LESS THAN TWO YEARS OLD1 | |
Bailey et al. | Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report | |
Demirkol et al. | Continuous venovenous hemodiafiltration in the treatment of maple syrup urine disease | |
Cerise et al. | Pancreas transplantation following total pancreatectomy for chronic pancreatitis | |
Moriguchi et al. | A patient with severe acute pancreatitis successfully treated with a new critical care procedure | |
Cransberg et al. | Pediatric renal transplantations in the Netherlands | |
Sanchorawala et al. | An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis | |
Ghidini et al. | Extraperitoneal kidney transplantation: a comparison between children weighting≤ 15 kg and> 15 kg. Experience of a single institution | |
Laine et al. | Renal transplantation in children with emphasis on young patients | |
Stefanidis et al. | Renal transplantation in children treated with continuous ambulatory peritoneal dialysis | |
Barry et al. | Pediatric cadaver kidney transplants into adults | |
Dainton | Acute kidney injury |